RS
Roivant Sciences Ltd.
ROIV· Health Care· BiotechnologyS&P 400
Close · 15/09/2026
39.50
1D
-3.71%52-week range
13.81 – 42.5
Volume
81,04,600.00
Price history
ROIV
14/08/2026 to 15/09/2026
O 41.14 H 41.14 L 39.22
1W-4.77%
1M+9.12%
3M+31.54%
6M+39.67%
1Y+180.54%
3Y+213.49%
5Y+296.19%
MAX+298.99%
Fundamentals
as of 15/09/2026- Market cap
- $28.53B
- Shares out
- 722.32M
- P/E (forward)
- -23.76
- EPS (trailing)
- -0.37
- Beta
- 1.12
- Profit margin
- -3534.96%
- P/B
- 6.74
- Return on equity
- -6.29%
SEC financial statements
19 quarterly and 6 annual periods through 30/06/2026.
Details
- Ticker
- ROIV
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 15/09/2026.
Tracked by Congress
1 filer · 0 on watchlist · 2 buys · 2 sells · R: 4
- 31/10/2025Lisa McClainSellRoivant Sciences Ltd. - Common Shares$1,001–$15,000
- 30/10/2025Lisa McClainSellRoivant Sciences Ltd. - Common Shares$1,001–$15,000
- 30/10/2025Lisa McClainBuyRoivant Sciences Ltd. - Common Shares$1,001–$15,000
- 17/06/2025Lisa McClainBuyRoivant Sciences Ltd. - Common Shares$1,001–$15,000